Effects of Intensive SBP Control in SPRINT on the SPRINT Primary and Secondary Outcomes in Baseline DBP of Less Than 60 mm Hg and Baseline DBP of Greater Than 60 mm Hg SubgroupĮTable 4. Adjusted Hazard Ratios for Mean Achieved DBP and Outcomes at Achieved SBP of Less Than 130 mm Hg in ACCORD-BP Trial in Intensive and Standard Glycemic Control GroupĮTable 3. Event Rates of the Primary and Secondary Outcomes Across Different Treated DBP Groups in Patients With Achieved SBP of Less Than 130 mm HgĮTable 2. Adjusted Hazard Ratios for Mean Achieved DBP and Outcomes at Achieved SBP of Less Than 130 mm Hg Using Integrated Data From SPRINT and ACCORD-BP After Additional Adjustment of Baseline PP, Baseline SBP, and Treated SBPĮTable 1. Adjusted Hazard Ratios for Mean Achieved DBP and Outcomes at Achieved SBP of Less Than 130 mm Hg Using Integrated Data From SPRINT and ACCORD-BP After Additional Adjustment of Baseline PP and Baseline DBPĮFigure 5. Adjusted Hazard Ratios for Mean Achieved DBP and Outcomes at Achieved SBP of 110 to Less Than 130 mm Hg Using Integrated Data From SPRINT and ACCORD-BPĮFigure 4. Adjusted Hazard Ratios for Mean Achieved DBP and Outcomes at Achieved SBP of Less Than 130 mm Hg in ACCORD-BP TrialĮFigure 3. Adjusted Hazard Ratios for Mean Achieved DBP and Outcomes at Achieved SBP of Less Than 130 mm Hg in SPRINT TrialĮFigure 2.
